Bill Text: TX SB2448 | 2023-2024 | 88th Legislature | Introduced


Bill Title: Relating to the use of funds appropriated by the Department of State Health Services to deliver low-dose, at-home racemic ketamine via telehealth to improve healthcare access and mental health outcomes across rural and high-risk populations.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2023-03-23 - Referred to Health & Human Services [SB2448 Detail]

Download: Texas-2023-SB2448-Introduced.html
 
 
  By: Menéndez S.B. No. 2448
 
 
 
   
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the use of funds appropriated by the Department of State
  Health Services to deliver low-dose, at-home racemic ketamine via
  telehealth to improve healthcare access and mental health outcomes
  across rural and high-risk populations.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 1001.203, Health and Safety Code is
  amended by adding Section 1001.2032 to read as follows:
         (1)  The purpose of this Act is to provide for expanded
  healthcare access, reduced care costs, improved mental health,
  reduced chronic pain, increased workforce productivity, improved
  trauma management for first responders and active military, and
  improved health rankings for rural and high-risk populations across
  Texas by authorizing the Department of State Health Services to
  fund low-dose, at-home ketamine using medical technology in the
  form of targeted intranasal delivery that can optimize the
  effectiveness of and reduce the potential side effects related to
  racemic ketamine treatments. 
         (2)  The Department of State Health Services shall direct
  funding to treat rural health population, first responders,
  veterans, and activity military with a clinical diagnosis of
  depression, post-traumatic stress disorder, anxiety, and chronic
  pain. The Department of State Health Services shall allocate a
  total of $55,000,000 for the purpose of providing funding during
  the state fiscal years ending August 31, 2024 and August 31, 2025
  for the treatment of at least 15,000 adults that are designated as
  living in a rural area of Texas, at least 8,000 first responders,
  and at least 6,000 veterans or active military. 
         (3)  The Department of State Health Services shall transfer
  the appropriations through contracts with low-dose, at-home
  racemic ketamine service providers that utilize targeted
  intranasal drug delivery. When treating mental health and
  neurological conditions, which requires the delivery of
  pharmaceutical agents to the brain, it is well understood that
  using oral administration is the least efficient and problematic
  route and intravenous or intramuscular administration prohibits
  at-home, self-administration, which is required to maximize access
  to care. The most optimized route of administration is intranasal,
  where certain regions of the nasal anatomy provide optimized
  pathways for drug delivery that can eliminate side effects that can
  reduce treatment compliance and maximize potential health
  outcomes. The treatment protocol shall not exceed 30 to 60
  milligrams of racemic ketamine per individual treatment and shall
  not exceed a total of 180 to 360 milligrams of racemic ketamine for
  the entire treatment program, as this sub-anesthetic and low-dose
  treatment protocol will minimize the potential for side-effects. 
         SECTION 2.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution, and shall
  expire September 1, 2025. 
         SECTION 3: The Department of State Health Services required
  to implement this Act only if the legislature appropriates money
  specifically for the purpose stated in SECTION 1 if this Act. If the
  legislature does not appropriate money specifically for that 
  purpose, the Department of State Health Services may, but is not
  required to, implement this Act using other appropriations
  available for the purpose. 
         SECTION 4.  This Act takes effect September 1, 2023. 
feedback